Covid-19 and pregnancy: the experience of a tertiary maternity hospital.


Journal

Journal of perinatal medicine
ISSN: 1619-3997
Titre abrégé: J Perinat Med
Pays: Germany
ID NLM: 0361031

Informations de publication

Date de publication:
27 Jul 2021
Historique:
received: 06 02 2021
accepted: 14 04 2021
pubmed: 30 6 2021
medline: 17 7 2021
entrez: 29 6 2021
Statut: epublish

Résumé

The aim of our study is to present the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy and evaluate its impact on maternal and neonatal outcomes. We retrospectively reviewed the medical records of all COVID-19 positive pregnant women who were admitted to "Alexandra" maternity hospital from March to December 2020 (n=40). The infection status was determined via real-time polymerase chain reaction (RT-PCR) of nasopharyngeal swab specimen. We documented the demographic features, clinical status, pregnancy characteristics and maternal and fetal outcomes. Forty COVID-19 positive pregnant women were admitted to our clinic during the study period. Mean maternal age was 27.6 years. Gestational age (GA) ranged from 10-42 weeks of pregnancy with mean GA calculated at 38 In alignment to other studies, our data show that the course of coronavirus disease 2019 (COVID-19) during pregnancy in the majority of cases is mild and neonatal outcomes also appear favorable.

Identifiants

pubmed: 34187133
pii: jpm-2021-0070
doi: 10.1515/jpm-2021-0070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

686-690

Informations de copyright

© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Références

Zhu, N, Zhang, D, Wang, W, Li, X, Yang, B, Song, J, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33. https://doi.org/10.1056/NEJMoa2001017.
WHO. Director-General’s opening remarks at the media briefing on COVID-19. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [Accessed 24 Dec 2020].
WHO. Coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/ [Accessed 24 Dec 2020].
Novel coronavirus 2019 (COVID-19). ACOG. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019 [Accessed 24 Dec 2020].
CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 – United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–6. https://doi.org/10.15585/mmwr.mm6913e2.
Zambrano, LD, Ellington, S, Strid, P, Galang, RR, Oduyebo, T, Tong, VT, et al.. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22–October 3, 2020. MMWR (Morb Mortal Wkly Rep) 2020;69:1641–7. https://doi.org/10.15585/mmwr.mm6944e3.
Dashraath, P, Wong, JIJ, Lim, MXK, Lim, LM, Li, S, Biswas, A, et al.. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521–31. https://doi.org/10.1016/j.ajog.2020.03.021.
Warning, JC, McCracken, SA, Morris, JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011;141:715–24. https://doi.org/10.1530/REP-10-0360.
Kirtsman, M, Diambomba, Y, Poutanen, SM, Malinowski, AK, Vlachodimitropoulou, E, Parks, WT, et al.. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ (Can Med Assoc J) 2020;192:E647–50. https://doi.org/10.1503/cmaj.200821.
Vivanti, AJ, Vauloup-Fellous, C, Prevot, S, Zupan, V, Suffee, C, Do Cao, J, et al.. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020;11:1–3572. https://doi.org/10.1038/s41467-020-17436-6.
Prabhu, M, Cagino, K, Matthews, KC, Friedlander, RL, Glynn, SM, Kubiak, JM, et al.. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG An Int J Obstet Gynaecol 2020;127:1548–56. https://doi.org/10.1111/1471-0528.16403.
Shanes, ED, Mithal, LB, Otero, S, Azad, HA, Miller, ES, Goldstein, JA, et al.. Placental pathology in COVID-19. Am J Clin Pathol 2020;154:23–32. https://doi.org/10.1093/ajcp/aqaa089.
Smithgall, MC, Liu-Jarin, X, Hamele-Bena, D, Cimic, A, Mourad, M, Debelenko, L, et al.. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology 2020;77:994–9. https://doi.org/10.1111/his.14215.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc 2013;310:2191–4. https://doi.org/10.1001/jama.2013.281053.
Sutton, D, Fuchs, K, D’Alton, M, Goffman, D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med 2020;382:2163–4. https://doi.org/10.1056/NEJMc2009316.
Chen, H, Guo, J, Wang, C, Luo, F, Yu, X, Zhang, W, et al.. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395:809–15. https://doi.org/10.1016/S0140-6736(20)30360-3.
RCOG. Coronavirus (COVID-19) infection and pregnancy. Available from: https://www.rcog.org.uk/coronavirus-pregnancy [Accessed 24 Dec 2020].
RCOG. Coronavirus (COVID-19) infection in pregnancy. Information for healthcare professionals, Version 13; 2021. https://www.rcog.org.uk/globalassets/documents/guidelines/2021-02-19-coronavirus-covid-19-infection-in-pregnancy-v13.pdf [Accessed 19 Feb 2021].
Novel Coronavirus 2019 (COVID-19). ACOG. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019 [Accessed 10 Jan 2021].
Api, O, Sen, C, Debska, M, Saccone, G, D’Antonio, F, Volpe, N, et al.. Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine. J Perinat Med 2020;48:857–66. https://doi.org/10.1515/jpm-2020-0265.
FDA. FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. US FDA. Available from: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19 [Accessed 24 Dec 2020].
ACOG. Vaccinating pregnant and lactating patients against COVID 19. Practice advisory. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19 [Accessed 24 Dec 2020].
Schalkwyk, V. SOGC statement on COVID-19 vaccination in pregnancy; 2020. Available from: https://sogc.org/common/Uploaded%20files/Latest%20News/SOGC_Statement_COVID-19_Vaccination_in_Pregnancy.pdf [Accessed 18 Dec 2020].

Auteurs

Panagiotis Antsaklis (P)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Konstantinos Tasias (K)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Alexandros Psarris (A)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Marianna Theodora (M)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

George Daskalakis (G)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Alexandros Rodolakis (A)

1st Department of Obstetrics and Gynecology, "Alexandra" Maternity Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH